GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that Stuart A. Randle, chief executive officer, will participate in a panel discussion as part of the 2010 Medical Innovation Summit being held at the Cleveland Clinic November 1-3, 2010 in Cleveland, Ohio. The focus of this year's summit, obesity, diabetes and the metabolic crisis, will bring together international leaders and researchers in healthcare to share their perspectives and discuss innovations in the way these diseases may be prevented, managed and treated.
“The Revolution in Diabetes Treatment, Surgical Intervention & Novel Therapies Explored”
"Forums like the Medical Innovation Summit provide an opportunity to engage, educate and learn about existing best practices and new treatment approaches that will help improve and manage these twin epidemics, and shape the future of patient care," said Mr. Randle. "I am pleased to be part of this forum, and appreciate the opportunity to contribute our thinking and insights gleaned from our efforts to develop the EndoBarrier, a non-surgical therapeutic for the treatment of type 2 diabetes and obesity."
Mr. Randle will participate in a panel, "The Revolution in Diabetes Treatment, Surgical Intervention & Novel Therapies Explored," on November 3, 2010 at 9:10 a.m. (EDT). Panelists will discuss forthcoming diabetes disease management and therapeutic treatment options, including GI Dynamics' EndoBarrier Gastrointestinal Liner.